Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2008 Jul 29;5(7):e164.
doi: 10.1371/journal.pmed.0050164.

Transmitted minority drug-resistant HIV variants: a new epidemic?

Steven G Deeks  1
Affiliations
Comment

Transmitted minority drug-resistant HIV variants: a new epidemic?

Steven G Deeks. PLoS Med. .

Abstract

Steven Deeks discusses a new study that investigates the prevalence and clinical implications of transmitted minority drug-resistant HIV variants.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: SGD has an ongoing research collaboration with Monogram Biosciences, which develops diagnostics for the monitoring of drug resistance, and has acted as a consultant for the company in the past. The company played no role in the preparation of this article.

Comment on

References

    1. Phillips AN, Leen C, Wilson A, Anderson J, Dunn D, et al. Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: An observational cohort study. Lancet. 2007;370:1923–1928. - PubMed
    1. Piantadosi A, Chohan B, Chohan V, McClelland RS, Overbaugh J. Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog. 2007;3:e177. doi: 10.1371/journal.ppat.0030177. - DOI - PMC - PubMed
    1. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, et al. HIV drug resistance acquired through superinfection. AIDS. 2005;19:1251–1256. - PubMed
    1. Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, et al. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA. 2002;288:181–188. - PubMed
    1. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347:385–394. - PubMed

Publication types

Substances